» Articles » PMID: 36429432

Cervical Microbiome in Women Infected with HPV16 and High-Risk HPVs

Overview
Publisher MDPI
Date 2022 Nov 26
PMID 36429432
Authors
Affiliations
Soon will be listed here.
Abstract

Human papillomavirus type 16 (HPV16) and/or high-risk (Hr-) HPV are the main causes of cervical cancer. Another element that may contribute to the development of cervical cancer is the microbiota. To date, no study has investigated the entire cervical microbiome, which consists of bacteria, fungi, and viruses. In this study, cervical samples with different histopathology (CIN1, CIN2, and CIN3), with or without HPV16 and Hr-HPVs infection, were enrolled. From bacterial community analysis, 115 bacterial species were found and separated into 2 distinct categories based on abundance: Lactobacilli-dominated (LD) and non-Lactobacilli-dominated (NLD) groups. The LD group had significantly less bacterial diversity than the NLD group. In addition, the variety of bacteria was contingent on the prevalence of HPV infection. Among distinct histological groups, an abundance of (>60% of total spp.) was discovered in both groups. A few fungi, e.g., , were identified in the fungal community. The viral community analysis revealed that the presence of HPV considerably reduced the diversity of human viruses. Taken together, when we analyzed all our results collectively, we discovered that HPV infection was a significant determinant in the diversity of bacteria and human viruses in the cervix.

Citing Articles

Viruses in the female lower reproductive tract: a systematic descriptive review of metagenomic investigations.

Honorato L, Paiao H, da Costa A, Tozetto-Mendoza T, Mendes-Correa M, Witkin S NPJ Biofilms Microbiomes. 2024; 10(1):137.

PMID: 39587088 PMC: 11589587. DOI: 10.1038/s41522-024-00613-6.


Microbiome markers in HPV-positive and HPV-negative women of reproductive age with ASCUS and SIL determined by V4 region of 16S rRNA gene sequencing.

Peremykina A, Cheranev V, Krivoy A, Andreev A, Repinskaia Z, Asaturova A Front Microbiol. 2024; 15:1334502.

PMID: 38550866 PMC: 10973545. DOI: 10.3389/fmicb.2024.1334502.


Human Papillomavirus Infections and the Role Played by Cervical and Cervico-Vaginal Microbiota-Evidence from Next-Generation Sequencing Studies.

Glowienka-Stodolak M, Baginska-Drabiuk K, Szubert S, Hennig E, Horala A, Dabrowska M Cancers (Basel). 2024; 16(2).

PMID: 38254888 PMC: 10814012. DOI: 10.3390/cancers16020399.


Human papillomavirus associated cervical lesion: pathogenesis and therapeutic interventions.

Ye J, Zheng L, He Y, Qi X MedComm (2020). 2023; 4(5):e368.

PMID: 37719443 PMC: 10501338. DOI: 10.1002/mco2.368.


Women's Health and Gynecology: Old Challenges and New Insights.

Sarria-Santamera A, Lagana A, Terzic M Int J Environ Res Public Health. 2022; 19(24).

PMID: 36554470 PMC: 9779633. DOI: 10.3390/ijerph192416589.

References
1.
Bradford L, Ravel J . The vaginal mycobiome: A contemporary perspective on fungi in women's health and diseases. Virulence. 2016; 8(3):342-351. PMC: 5411243. DOI: 10.1080/21505594.2016.1237332. View

2.
Gajer P, Brotman R, Bai G, Sakamoto J, Schutte U, Zhong X . Temporal dynamics of the human vaginal microbiota. Sci Transl Med. 2012; 4(132):132ra52. PMC: 3722878. DOI: 10.1126/scitranslmed.3003605. View

3.
Bauman N, Smith R . Recurrent respiratory papillomatosis. Pediatr Clin North Am. 1996; 43(6):1385-401. DOI: 10.1016/s0031-3955(05)70524-1. View

4.
Sirichoat A, Buppasiri P, Engchanil C, Namwat W, Faksri K, Sankuntaw N . Characterization of vaginal microbiota in Thai women. PeerJ. 2018; 6:e5977. PMC: 6252066. DOI: 10.7717/peerj.5977. View

5.
Egawa N, Doorbar J . The low-risk papillomaviruses. Virus Res. 2017; 231:119-127. DOI: 10.1016/j.virusres.2016.12.017. View